Chemomab Therapeutics Corporate Overview 2022

Clinical-stage biotech company focused on discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet medical need. Chemomab's pipeline includes CM-101 and other product candidates targeting the intersection of fibrosis and inflammation.